More than 56 million pieces of 5 ml auto disabled (AD) syringes for intramuscular syringes have been delivered to Covax facility
Hindustan Syringes & Medical Devices (HMD) has sent its first shipment of 56 million pieces of KOJAK auto disable (AD) syringes to Covax facility.
The Covax facility working for global equitable access to COVID-19 vaccines which is a pooled procurement mechanism for new COVID-19 vaccines, through which Covax will ensure fair and equitable access to vaccines for each participating economy has ordered 140 million KOJAK AD Syringes from HMD to be supplied between August and December 2020.
“We have shipped out more than 56 million pieces of 5 ml auto disabled (AD) syringes for intramuscular syringes to Covax facility and will soon send the next shipment of 28 million Syringes by October end,” said Rajiv Nath, MD, Hindustan Syringes & Medical Devices.
“Should the government need 100 million KOJAK AD syringes for COVID-19 vaccines by the end of this year, we can easily offer them to lift the outstanding orders placed with us. However, Indian government is yet to make a move or order though they have started consulting manufacturers for spare capacity availability beyond the standard immunisation programme. We plan to allocate 50 per cent of the total 0.5 ML AD Syringes produced for the government of India and 50 per cent for export as we have got a global responsibility too. But we would appreciate a clarity from the government soon,” added Nath.
HMD has planned to scale up its production capacity to one billion of 0.5 ML by middle of 2021 from 700 million AD syringes a year.
